Literature DB >> 19529854

Anticoagulant effects of a complex of high molecular weight heparin and arginine.

L A Lyapina1, T Yu Obergan, V E Pastorova.   

Abstract

Heparin forms a complex compound with arginine in a pure system, which was shown by biochemical methods. A method for obtaining the complex in vitro has been developed. At arginine/heparin molar ratio of 3:1 the complex exhibited anticoagulant, antiplatelet, and fibrin-depolymerization activities. High fibrin-depolymerization and anticoagulant activities were documented in the blood of animals 10 min after intravenous injection of the arginine-heparin complex, in contrast to the picture after injection of the complex components (heparin and arginine) alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19529854     DOI: 10.1007/s10517-009-0501-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection.

Authors:  Kuntal Sen; Dana Harrar; Andrea Hahn; Elizabeth M Wells; Andrea L Gropman
Journal:  J Neurol       Date:  2021-04-01       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.